vs
Side-by-side financial comparison of BioNTech SE (BNTX) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.
BioNTech SE is the larger business by last-quarter revenue ($1.5B vs $1.0B, roughly 1.5× Everus Construction Group, Inc.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs -1.9%, a 7.4% gap on every dollar of revenue.
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
BNTX vs ECG — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.0B |
| Net Profit | $-28.7M | $55.3M |
| Gross Margin | — | 11.6% |
| Operating Margin | -3.1% | 6.8% |
| Net Margin | -1.9% | 5.5% |
| Revenue YoY | — | 33.2% |
| Net Profit YoY | — | 60.4% |
| EPS (diluted) | — | $1.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.0B | ||
| Q3 25 | $1.5B | $986.8M | ||
| Q2 25 | $260.8M | $921.5M | ||
| Q1 25 | — | $826.6M | ||
| Q4 24 | — | $759.6M | ||
| Q3 24 | $1.2B | $761.0M | ||
| Q2 24 | — | $703.4M | ||
| Q1 24 | — | $625.7M |
| Q4 25 | — | $55.3M | ||
| Q3 25 | $-28.7M | $57.0M | ||
| Q2 25 | $-386.6M | $52.8M | ||
| Q1 25 | — | $36.7M | ||
| Q4 24 | — | $34.5M | ||
| Q3 24 | $198.1M | $41.8M | ||
| Q2 24 | — | $39.0M | ||
| Q1 24 | — | $28.2M |
| Q4 25 | — | 11.6% | ||
| Q3 25 | — | 12.6% | ||
| Q2 25 | — | 13.0% | ||
| Q1 25 | — | 11.2% | ||
| Q4 24 | — | 11.4% | ||
| Q3 24 | — | 11.8% | ||
| Q2 24 | — | 12.6% | ||
| Q1 24 | — | 11.9% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | -3.1% | 7.3% | ||
| Q2 25 | -192.1% | 7.9% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | 0.8% | 7.1% | ||
| Q2 24 | — | 7.3% | ||
| Q1 24 | — | 6.2% |
| Q4 25 | — | 5.5% | ||
| Q3 25 | -1.9% | 5.8% | ||
| Q2 25 | -148.2% | 5.7% | ||
| Q1 25 | — | 4.4% | ||
| Q4 24 | — | 4.5% | ||
| Q3 24 | 15.9% | 5.5% | ||
| Q2 24 | — | 5.5% | ||
| Q1 24 | — | 4.5% |
| Q4 25 | — | $1.09 | ||
| Q3 25 | — | $1.11 | ||
| Q2 25 | — | $1.03 | ||
| Q1 25 | — | $0.72 | ||
| Q4 24 | — | $0.68 | ||
| Q3 24 | — | $0.82 | ||
| Q2 24 | — | $0.76 | ||
| Q1 24 | — | $0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | $281.5M |
| Stockholders' EquityBook value | — | $629.8M |
| Total Assets | — | $1.7B |
| Debt / EquityLower = less leverage | — | 0.45× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $553.0K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $281.5M | ||
| Q3 25 | — | $285.1M | ||
| Q2 25 | — | $288.6M | ||
| Q1 25 | — | $292.1M | ||
| Q4 24 | — | $295.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $629.8M | ||
| Q3 25 | — | $573.0M | ||
| Q2 25 | — | $514.4M | ||
| Q1 25 | — | $460.2M | ||
| Q4 24 | — | $422.6M | ||
| Q3 24 | — | $453.3M | ||
| Q2 24 | — | $490.0M | ||
| Q1 24 | — | $464.3M |
| Q4 25 | — | $1.7B | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | 0.56× | ||
| Q1 25 | — | 0.63× | ||
| Q4 24 | — | 0.70× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $48.2M |
| Free Cash FlowOCF − Capex | — | $23.5M |
| FCF MarginFCF / Revenue | — | 2.3% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.87× |
| TTM Free Cash FlowTrailing 4 quarters | — | $90.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $48.2M | ||
| Q3 25 | — | $76.2M | ||
| Q2 25 | — | $25.3M | ||
| Q1 25 | — | $7.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $78.9M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $21.9M |
| Q4 25 | — | $23.5M | ||
| Q3 25 | — | $65.7M | ||
| Q2 25 | — | $12.3M | ||
| Q1 25 | — | $-11.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $60.9M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $12.6M |
| Q4 25 | — | 2.3% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | -1.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 8.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.0% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.5% |
| Q4 25 | — | 0.87× | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | — | 0.48× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.89× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.77× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BNTX
Segment breakdown not available.
ECG
| Commercial | $594.5M | 59% |
| Utility | $203.5M | 20% |
| Industrial | $82.8M | 8% |
| Institutional | $66.1M | 7% |
| Service And Other | $28.4M | 3% |
| Transportation | $24.2M | 2% |
| Renewables | $19.8M | 2% |
